Risk factors

Telomir Pharmaceuticals (TELO) risk factors

Item 1A of every Telomir Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next.

Open TELO in Gloomberb →
  • FY2025 10-K risk factors

    65 risks, 15 new, 3 dropped, 7 reworded since the prior year. Telomir faces significant going concern doubts with zero revenues and a reliance on external financing.

    Filed Mar 17, 2026
  • FY2024 10-K risk factors

    53 risks. The company relies entirely on in-licensed pre-clinical asset Telomir-1 without owning underlying patents.

    Filed Feb 04, 2025